The State of AI in Clinical Trials — 2026 Report
Supplied by Medidata Solutions on Wednesday, 12 August, 2026
AI is moving beyond experimentation in clinical research. See how early adopters are improving trial performance, overcoming scaling barriers, and unlocking the next generation of AI-driven clinical development.
What’s inside the 2026 report:
·Early Adopter Advantage: Where AI leaders are seeing the biggest gains.
·AI in Action: Key areas where AI is delivering measurable results today.
·Scaling Success: The barriers to enterprise-wide adoption — and how to overcome them.
·What’s Next: Emerging trends, from protocol simulation to autonomous agents.
SARS-Cov-2 variants with spike protein gene mutations
Learn about innovative SARS-Cov-2 tests that...
Eliminate compliance challenges and costs of quality improvement in hospitals
Learn how to streamline the safety and quality...
Hospital intelligence surges with new smart technology
Learn how to leverage the latest technology to create new and better clinical processes and...
